Revolution Medicines, Inc. (RVMD)
147.02
-4.05
(-2.68%)
USD |
NASDAQ |
May 07, 09:41
Revolution Medicines SG&A Expense (TTM) : 195.04M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Tango Therapeutics, Inc. | 41.51M |
| AtriCure, Inc. | 234.96M |
| Eli Lilly & Co. | 11.56B |
| Travere Therapeutics, Inc. | 264.36M |
| Kymera Therapeutics, Inc. | 72.27M |